The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
暂无分享,去创建一个
Sun-Mi Park | A. Gaur | E. Lengyel | M. Peter
[1] H. Dvorak. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.
[2] E. Hay. An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.
[3] Christian A. Rees,et al. Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.
[4] D. Dean,et al. Differential expression and function of members of the zfh-1 family of zinc finger/homeodomain repressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[5] P. Savagner,et al. Leaving the neighborhood: molecular mechanisms involved during epithelial‐mesenchymal transition , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[6] G. Berx,et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.
[7] J. Zavadil,et al. Genetic programs of epithelial cell plasticity directed by transforming growth factor-β , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[9] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[10] Birgit Luber,et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. , 2002, The American journal of pathology.
[11] Wolfgang Henrich,et al. The prognostic significance of epithelial-mesenchymal transition in breast cancer. , 2002, Anticancer research.
[12] Alicia Algeciras-Schimnich,et al. Two CD95 tumor classes with different sensitivities to antitumor drugs , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Peter,et al. CD95 ligand induces motility and invasiveness of apoptosis‐resistant tumor cells , 2004, The EMBO journal.
[14] Y. Yatabe,et al. Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.
[15] F. Portillo,et al. Transcriptional regulation of cadherins during development and carcinogenesis. , 2004, The International journal of developmental biology.
[16] F. Slack,et al. RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.
[17] K. Imai,et al. Expression of SIP1 in oral squamous cell carcinomas: implications for E-cadherin expression and tumor progression. , 2005, International journal of oncology.
[18] José Miguel García,et al. E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. , 2005, Human molecular genetics.
[19] G. Berx,et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells , 2005, Oncogene.
[20] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[21] F. Slack,et al. Reciprocal expression of lin‐41 and the microRNAs let‐7 and mir‐125 during mouse embryogenesis , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.
[22] J. Nesland,et al. Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma , 2005, Cancer.
[23] J. Thiery,et al. Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.
[24] R. Stephens,et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.
[25] J. Foidart,et al. Regulation of vimentin by SIP1 in human epithelial breast tumor cells , 2006, Oncogene.
[26] B. Davidson,et al. Expression of E-cadherin transcriptional regulators in ovarian carcinoma , 2006, Virchows Archiv.
[27] Mariette Schrier,et al. A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors , 2006, Cell.
[28] S. Spivack,et al. Potential mRNA Degradation Targets of hsa-miR-200c , 2006, Cell cycle.
[29] S. Jakowlew. Transforming growth factor-β in cancer and metastasis , 2006, Cancer and Metastasis Reviews.
[30] K. Horwitz,et al. The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. , 2006, Cancer research.
[31] A. Muñoz,et al. The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E‐cadherin and vitamin D receptor in human colon carcinomas , 2006, International journal of cancer.
[32] Y. Akao,et al. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. , 2006, Biological & pharmaceutical bulletin.
[33] Sun-Mi Park,et al. CD95 signaling deficient mice with a wild-type hematopoietic system are prone to hepatic neoplasia , 2007, Apoptosis.
[34] T. Gress,et al. Collagen type I-induced Smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer , 2007, Oncogene.
[35] Asli Silahtaroglu,et al. miR-200b mediates post-transcriptional repression of ZFHX1B. , 2007, RNA.
[36] Kohei Miyazono,et al. Differential Regulation of Epithelial and Mesenchymal Markers by δEF1 Proteins in Epithelial–Mesenchymal Transition Induced by TGF-β , 2007 .
[37] F. Slack,et al. The let-7 microRNA represses cell proliferation pathways in human cells. , 2007, Cancer research.
[38] K. Kimura,et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. , 2007, The Journal of clinical investigation.
[39] Sun-Mi Park,et al. Let-7 Prevents Early Cancer Progression by Suppressing Expression of the Embryonic Gene HMGA2 , 2007, Cell cycle.
[40] Héctor Peinado,et al. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.
[41] G. Gores,et al. mir-29 regulates Mcl-1 protein expression and apoptosis , 2007, Oncogene.
[42] S. Spivack,et al. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. , 2007, Cancer research.
[43] E. Kistner,et al. Let-7 expression defines two differentiation stages of cancer , 2007, Proceedings of the National Academy of Sciences.
[44] E. Kistner,et al. c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. , 2007, Cancer research.
[45] S. Badve,et al. NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2 , 2007, Oncogene.
[46] R. Foisner,et al. The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity , 2007, Oncogene.
[47] Jason H. Moore,et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. , 2007, Cancer research.
[48] G. Goodall,et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.
[49] C. Burge,et al. Identification of let-7-regulated oncofetal genes. , 2008, Cancer research.